Disappointing results with major studies with torcetrapib
Results from ILLUSTRATE and RADIANCE failed to demonstrate any benefit
on progression of atherosclerosis with torcetrapib administered in
combination with atorvastatin, despite substantial increases in HDL
cholesterol.